Selcuk Ecza Deposu Ticaret venayi ASIST:SELEC +6.80%79 Net Current Asset Value is ₺34.52 as of Mar. 2026, which is 100% below its 10-year median of 2.15. GuruFocus rates IST:SELEC with a GF Score™ of 79/100 and a GF Value™ of ₺87.25 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 75 Medical Distribution companies, Selcuk Ecza Deposu Ticaret venayi AS ranks worse than 76% on this metric.
In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).
The historical rank and industry rank for Selcuk Ecza Deposu Ticaret venayi AS's Net Current Asset Value or its related term are showing as below:
IST:SELEC'
s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 1 Med: 2.15 Max: 6.46
Current: 6.46
During the past 13 years, the highest Price-to-Net-Current-Asset-Value Ratio of Selcuk Ecza Deposu Ticaret venayi AS was 6.46. The lowest was 1.00. And the median was 2.15.
IST:SELEC's Price-to-Net-Current-Asset-Value is ranked worse than 76% of 75
companies
in the Medical Distribution industry
Industry Median: 3.15
vs IST:SELEC: 6.46
Selcuk Ecza Deposu Ticaret venayi AS (IST:SELEC) Net Current Asset Value Explanation
Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."
The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]
Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Grahams strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.
Selcuk Ecza Deposu Ticaret venayi AS Net Current Asset Value Related Terms
Selcuk Ecza Deposu Ticaret venayi AS Net Current Asset Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Selcuk Ecza Deposu Ticaret venayi AS Net Current Asset Value Chart
IST:SELEC vs MCK, CAH, COR: Net Current Asset Value Comparison
For the Medical Distribution subindustry, Selcuk Ecza Deposu Ticaret venayi AS's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Selcuk Ecza Deposu Ticaret venayi AS Price-to-Net-Current-Asset-Value vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Selcuk Ecza Deposu Ticaret venayi AS's Price-to-Net-Current-Asset-Value distribution charts can be found below:
* The bar in red indicates where Selcuk Ecza Deposu Ticaret venayi AS's Price-to-Net-Current-Asset-Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Net Current Asset Value of ₺34.52 mean?
Selcuk Ecza Deposu Ticaret venayi AS (IST:SELEC) has a Net Current Asset Value of ₺34.52 as of Mar. 2026. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Selcuk Ecza Deposu Ticaret venayi AS and its competitors. This is 1506% above median its historical median of 2.15. Over the past decade, Selcuk Ecza Deposu Ticaret venayi AS's Net Current Asset Value has ranged from 1.00 to 6.46. According to the industry distribution chart, Selcuk Ecza Deposu Ticaret venayi AS ranks #57 out of 75 companies in the Medical Distribution industry, placing it in the top 76%.
Is Selcuk Ecza Deposu Ticaret venayi AS's Net Current Asset Value too high?
Selcuk Ecza Deposu Ticaret venayi AS's current Net Current Asset Value of ₺34.52 is 1506% above median its 10-year median of 2.15. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 6.46. Based on the distribution chart, Selcuk Ecza Deposu Ticaret venayi AS ranks #57 out of 75 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Selcuk Ecza Deposu Ticaret venayi AS has a GF Score™ of 79/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Selcuk Ecza Deposu Ticaret venayi AS's Net Current Asset Value compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Selcuk Ecza Deposu Ticaret venayi AS ranks #57 out of 75 companies for Net Current Asset Value. This places Selcuk Ecza Deposu Ticaret venayi AS in the lower half of its industry. The industry median Net Current Asset Value is 3.15. Historically, Selcuk Ecza Deposu Ticaret venayi AS's own Net Current Asset Value has ranged from 1.00 to 6.46 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Medical Distribution company?
The median Net Current Asset Value among Medical Distribution companies is 3.15, based on 75 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Selcuk Ecza Deposu Ticaret venayi AS and its competitors. For the Medical Distribution industry, the median Net Current Asset Value is 3.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Selcuk Ecza Deposu Ticaret venayi AS's current Net Current Asset Value is ₺34.52, which is 1506% above median its own 10-year median of 2.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Selcuk Ecza Deposu Ticaret venayi AS stock overvalued right now?
Based on GuruFocus' analysis, Selcuk Ecza Deposu Ticaret venayi AS (IST:SELEC) is currently considered Significantly Overvalued. The stock's GF Value™ is ₺87.25, compared to a current price of ₺223.00 — trading 155.6% above its estimated fair value. The current Net Current Asset Value is ₺34.52, which is 1506% above median its 10-year median of 2.15. Selcuk Ecza Deposu Ticaret venayi AS's overall GF Score™ is 79/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For Selcuk Ecza Deposu Ticaret venayi AS (IST:SELEC), the current Net Current Asset Value is ₺34.52 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Selcuk Ecza Deposu Ticaret venayi AS (IST:SELEC) Overvalued in 2026?
Based on GuruFocus' analysis, Selcuk Ecza Deposu Ticaret venayi AS stock appears to be overvalued.
The current stock price of ₺223.00 is trading 155.6% above its estimated GF Value™ of ₺87.25.
GuruFocus considers Selcuk Ecza Deposu Ticaret venayi AS to be Significantly Overvalued.
Key valuation signals for IST:SELEC:
Net Current Asset Value: ₺34.52 (1506% above median its 10-year median of 2.15)
GF Value™: ₺87.25 vs. price of ₺223.00 (155.6% above fair value)
No single metric tells the full story. See the IST:SELEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Selcuk Ecza Deposu Ticaret venayi AS Business Description
Selcuk Ecza Deposu Ticaret ve Sanayi AS and its subsidiaries are in the business of export and import of drugs and patent medicines, medical supplies with pharmacy depot operations and also organize distribution channels between drug manufacturers, hospitals, and pharmacies. The company also distributes cosmetics, personal care, infant food, vitamins, medical and similar products.
79GF Score
Get the complete analysis for IST:SELEC
Net Current Asset Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IST:SELEC has been successfully added to your 
